Banner
Home

Private equity, physician-owned centers & more: Dr. Michael Rivers on ASC trends Print E-mail
Written by FHInews   
Tuesday, 16 July 2019 00:00

Rachel Popa interviews Michael Rivers, MD, Director of EMA Ophthalmology for EHR developer Modernizing Medicine, based in Boca Raton, for Becker's ASC on July 16, 2019. He weighed in on the key ASC trends this year.

Question: What trends should ASC leaders expect to see this year?

Dr. Michael Rivers: ASCs are drawing increasing market emphasis in specialty practices, specifically ophthalmology and gastroenterology, due to the profitability potential for doctors combined with the cost-effectiveness for patients...

Read More

Last Updated on Friday, 19 July 2019 16:42
 
Confused about what to eat? Science can help Print E-mail
Written by FHI's Week in Review   
Monday, 08 July 2019 14:31

A July 5th strawberrypost in The Conversation clears up a lot of confusion, including among doctors, about proper nutrition. Author P.K. Newby, a nutrition scientist, points out that, despite seemingly conflicting advice from so-called experts, there is broad consensus in the scientific community supporting a plant-based diet.  According to the author:

While it may sound like a fad, a plant-based diet has been studied for decades. Awareness escalated as it addresses two urgent public health challenges: the chronic disease epidemic and the climate change crisis. It's a win-win for human health and the environment.

Read More

Last Updated on Monday, 08 July 2019 14:39
 
Executive Order on Hospital Price Transparency May Prompt Disclosure of Negotiated Prices Print E-mail
Written by FHI's Week in Review   
Monday, 01 July 2019 12:50

Emily J. Cook, Michael B. Kimberly, Paul W. Hughes
and Steven J. Schnelle offer an inside look at the recent White House order in a June 28 MWE.com  post:  
 
President Trump has issued an Executive Order instructing several federal agencies to begin rulemaking processes intended to increase the transparency of hospital pricing. Among other measures, the Executive Order directs the Secretary of the US Department of Health and Human Services to begin a rulemaking process that would require hospitals to publicly post commercially negotiated rates with third-party payors. This On the Subject provides an overview of historic developments in the regulation of hospital price transparency, summarizes key provisions of the Executive Order and analyzes various aspects of the Executive Order relevant to industry stakeholders.

Read more in the current issue of Week in Review>>

Last Updated on Monday, 01 July 2019 13:08
 
The ethics behind the world's most expensive medication Print E-mail
Written by FHI's Week in Review   
Monday, 17 June 2019 11:52

Robert Pearl, MD, in a KevinMD post dated June 14, 2019, states:
 
With the recent FDA approval, Zolgensma <Novartis AG> became the  world's most expensive medication. Priced at $2.125 million per patient, the one-dose gene therapy is a potential life-saver for children with spinal muscular atrophy (SMA). Now, the treatment is at the center of an intensifying debate over the rising price of medications

Read more in the current issue of Week in Review>> https://conta.cc/2XjsN8m

Last Updated on Saturday, 22 June 2019 16:01
 
Sponsor Showcase Print E-mail
Written by Sponsor   
Tuesday, 02 July 2019 00:00
 
bdo-ftl hc florida-health-industry ad 1-19
Last Updated on Tuesday, 02 July 2019 17:14
 


Banner
Website design, development, and hosting provided by
Netphiles